|
시장보고서
상품코드
1463044
DNA 시퀀싱 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품 및 서비스별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)DNA Sequencing Market Share, Size, Trends, Industry Analysis Report, By Product and Services (Instruments, Consumables, Services); By Technology; By Application; By End Use; By Region; Segment Forecast, 2024- 2032 |
||||||
Polaris Market Research의 최신 연구에 따르면, 세계 DNA 시퀀싱 시장 규모는 2032년까지 707억 4,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
DNA 시퀀싱 시장은 게놈 연구의 성장으로 빠르게 성장하고 있습니다. 기술 발전으로 인한 시퀀싱 비용의 감소와 자금 조달의 증가는 특히 인간 게놈의 복잡성을 해독하고 질병 유전학을 이해하는 등의 연구를 촉진하고 있습니다. 인간 건강뿐만 아니라 게놈 연구는 농업, 미생물학, 환경 과학에도 적용되고 있으며, DNA 시퀀싱은 작물 개량, 질병 저항성, 미생물 군집 분석에 도움이 되고 있습니다. 고처리 시퀀싱 및 단일 세포 기술과 같은 혁신은 연구 능력을 향상시키고 유전자 데이터의 신속한 분석을 용이하게 했습니다.
DNA 시퀀싱 기술은 유전성 질환, 감염성 질환 및 각종 암 진단에 매우 중요한 역할을 합니다. 정확성, 속도 및 비용 효율성이 향상됨에 따라 이러한 기술은 점점 더 임상에 통합되고 있습니다. 유전질환의 조기 발견과 정확한 진단을 돕고, 감염성 질환의 신속한 병원체 식별을 촉진하며, 표적 치료법을 찾아내어 암 진단에 혁명을 일으키고 있습니다. 기술의 발전과 비용 절감으로 DNA 시퀀싱은 일상적인 임상 진료에 더욱 필수적인 요소로 자리 잡으며 시장 확대를 더욱 촉진할 것으로 예상됩니다.
DNA 시퀀싱 시장은 개인의 유전자 프로파일을 기반으로 치료법을 맞춤화하는 동반진단의 채택이 증가함에 따라 DNA 시퀀싱은 치료 방침을 결정하는 데 중요한 유전 정보를 제공하는 데 중요한 역할을 하고 있습니다. 동반진단은 질병 및 치료 반응과 관련된 유전자 바이오마커를 찾아내어 표적 치료 및 치료 결과를 개선할 수 있도록 돕습니다. 유전체 연구와 개인 맞춤형 의료 이니셔티브의 발전으로 다양한 의료 전문 분야에서 그 유용성이 확대되고 있으며, FDA와 같은 규제 기관은 표적 치료 승인을 지원하는 동반진단을 적극적으로 홍보하고 의료 서비스 제공자가 임상 의사 결정에 통합하도록 장려하고 있습니다.
농업 분야에서 DNA 시퀀싱은 병에 강한 작물과 가축의 육종 프로그램을 강화하고, 마커 지원 방법과 게놈 선발 방법을 통해 유전형질 식별을 가속화할 수 있습니다. 또한 토양 미생물 군집과 영양소 흡수에 대한 인사이트를 바탕으로 시비, 해충 방제, 관개 방법을 최적화함으로써 정밀 농업을 가능하게 합니다. 가축의 경우, DNA 시퀀싱은 유량, 질병 저항성 등 원하는 형질에 대한 유전적 마커를 식별하여 육종을 강화하고, 환경에 미치는 영향을 최소화하면서 생산성을 향상시킬 수 있습니다.
DNA 시퀀싱 시장 보고서 하이라이트
2023년 소모품 부문은 높은 사용률, 잦은 재구매, 다양한 용도로 인해 큰 매출 비중을 차지했습니다.
2023년 차세대 시퀀싱 부문은 처리량 증가, 비용 효율성, 임상 진단 분야에서의 사용 확대에 힘입어 큰 매출 점유율을 차지했습니다.
2023년에는 정밀의료, 조기 발견 및 진단, 치료 반응 모니터링에 중점을 두고 있는 암 분야가 큰 매출 비중을 차지했습니다.
2023년 학술 연구 부문은 자금 배분, 연구 강도 및 보조금 요구 사항으로 인해 큰 매출 점유율을 차지했습니다.
2023년 북미는 탄탄한 의료 인프라, 정부 자금, 높은 유전성 질환 유병률로 인해 세계 시장을 장악했습니다.
이 시장은 Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Merck KGaA, Qiagen N.V., Thermo Fisher Scientific Inc. 등 세계 시장 기업들이 존재하기 때문에 경쟁이 치열합니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 DNA 시퀀싱 시장 인사이트
- DNA 시퀀싱 - 업계 현황
- DNA 시퀀싱 시장 역학
- 성장 촉진요인과 기회
- 맞춤형 의료 수요 증가에 의해 제품 수요가 자극될 것으로 예측됩니다.
- 차세대 시퀀싱(NGS) 기술 진보에 의해 DNA 시퀀싱 시장의 성장이 촉진될 것으로 예상됩니다.
- 성장 억제요인과 과제
- 시퀀싱 기술의 고비용
- 성장 촉진요인과 기회
- PESTLE 분석
- DNA 시퀀싱 업계 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 용도별 세계 시장
- 주요 조사 결과
- 소개
- 임상 조사
- 종양학
- 소비자 유전체학
- 애그리유전체학와 포렌식
- 메타유전체학
- 역학과 의약품 개발
- 기타
제6장 기술별 세계 시장
- 주요 조사 결과
- 소개
- 차세대 시퀀싱
- 생어 시퀀싱
- 제3세대 시퀀싱
- 기타
제7장 최종 용도별 세계 시장
- 주요 조사 결과
- 소개
- 병원·클리닉
- 제약·바이오테크놀러지 기업
- 임상 연구
- 학술 연구
- 기타
제8장 제품과 서비스별
- 주요 조사 결과
- 소개
- 기기
- 소모품
- 서비스
제9장 지역별 세계 시장
- 주요 조사 결과
- 소개
- DNA 시퀀싱 시장 평가, 지역별, 2019-2032년
- DNA 시퀀싱 시장 - 북미
- 북미 : DNA 시퀀싱 시장, 용도별, 2019-2032년
- 북미 : DNA 시퀀싱 시장, 제품 및 서비스별, 2019-2032년
- 북미 : DNA 시퀀싱 시장, 기술별, 2019-2032년
- 북미 : DNA 시퀀싱 시장, 최종 용도별, 2019-2032년
- DNA 시퀀싱 시장 - 미국
- DNA 시퀀싱 시장 - 캐나다
- DNA 시퀀싱 시장 - 유럽
- 유럽 : DNA 시퀀싱 시장, 용도별, 2019-2032년
- 유럽 : DNA 시퀀싱 시장, 제품 및 서비스별, 2019-2032년
- 유럽 : DNA 시퀀싱 시장, 기술별, 2019-2032년
- 유럽 : DNA 시퀀싱 시장, 최종 용도별, 2019-2032년
- DNA 시퀀싱 시장 - 영국
- DNA 시퀀싱 시장 - 프랑스
- DNA 시퀀싱 시장 - 독일
- DNA 시퀀싱 시장 - 이탈리아
- DNA 시퀀싱 시장 - 스페인
- DNA 시퀀싱 시장 - 네델란드
- DNA 시퀀싱 시장 - 러시아
- DNA 시퀀싱 시장 - 아시아태평양
- 아시아태평양 : DNA 시퀀싱 시장, 용도별, 2019-2032년
- 아시아태평양 : DNA 시퀀싱 시장, 제품 및 서비스별, 2019-2032년
- 아시아태평양 : DNA 시퀀싱 시장, 기술별, 2019-2032년
- 아시아태평양 : DNA 시퀀싱 시장, 최종 용도별, 2019-2032년
- DNA 시퀀싱 시장 - 중국
- DNA 시퀀싱 시장 - 인도
- DNA 시퀀싱 시장 - 일본
- DNA 시퀀싱 시장 - 말레이시아
- DNA 시퀀싱 시장 - 인도네시아
- DNA 시퀀싱 시장 - 한국
- DNA 시퀀싱 시장 - 중동 및 아프리카
- 중동 및 아프리카 : DNA 시퀀싱 시장, 용도별, 2019-2032년
- 중동 및 아프리카 : DNA 시퀀싱 시장, 제품 및 서비스별, 2019-2032년
- 중동 및 아프리카 : DNA 시퀀싱 시장, 기술별, 2019-2032년
- 중동 및 아프리카 : DNA 시퀀싱 시장, 최종 용도별, 2019-2032년
- DNA 시퀀싱 시장 - 사우디아라비아
- DNA 시퀀싱 시장 - 남아프리카
- DNA 시퀀싱 시장 - 이스라엘
- DNA 시퀀싱 시장 - UAE
- DNA 시퀀싱 시장 - 라틴아메리카
- 라틴아메리카 : DNA 시퀀싱 시장, 용도별, 2019-2032년
- 라틴아메리카 : DNA 시퀀싱 시장, 제품 및 서비스별, 2019-2032년
- 라틴아메리카 : DNA 시퀀싱 시장, 기술별, 2019-2032년
- 라틴아메리카 : DNA 시퀀싱 시장, 최종 용도별, 2019-2032년
- DNA 시퀀싱 시장 - 멕시코
- DNA 시퀀싱 시장 - 브라질
- DNA 시퀀싱 시장 - 아르헨티나
제10장 경쟁 상황
- 확대와 인수 분석
- 확대
- 인수
- 파트너십/협업/계약/공개
제11장 기업 개요
- Abcam plc
- Agilent Technologies, Inc.
- Becton, Dickinson and Company(BD)
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Cell Biolabs, Inc.
- Cell Signaling Technology, Inc.
- Danaher Corporation
- GenScript Biotech Corporation
- Merck KGaA
- PerkinElmer, Inc.
- Promega Corporation
- Qiagen N.V.
- SignalChem Pharmaceuticals Inc.
- Thermo Fisher Scientific Inc.
The global DNA Sequencing market size is expected to reach USD 70.74 billion by 2032, according to a new study by Polaris Market Research. The report "DNA Sequencing Market Share, Size, Trends, Industry Analysis Report, By Product and Services (Instruments, Consumables, Services); By Technology; By Application; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The DNA sequencing market is rapidly expanding due to the growth of genomic research. Technological advancements reduced sequencing costs, and increased funding have driven research forward, particularly in deciphering the human genome's complexities and understanding disease genetics. Beyond human health, genomic research extends to agriculture, microbiology, and environmental science, where DNA sequencing aids in crop improvement, disease resistance, and microbial community analysis. Innovations such as high-throughput sequencing and single-cell techniques enhance research capabilities, facilitating rapid analysis of genetic data.
DNA sequencing technologies are pivotal in diagnosing genetic disorders, infectious diseases, and various cancer types. With improved accuracy, speed, and cost-effectiveness, these technologies are increasingly integrated into clinical practice. They aid in early detection and precise diagnosis of genetic disorders, facilitate rapid pathogen identification for infectious diseases, and revolutionize cancer diagnostics by identifying targeted therapies. As technology advances and costs decrease, DNA sequencing is expected to become even more integral to routine clinical practice, further driving market expansion.
The DNA sequencing market is fueled by the rising adoption of companion diagnostics, which customize treatments based on individual genetic profiles. DNA sequencing plays a vital role in providing crucial genetic information for treatment decisions. Companion diagnostics aid in identifying genetic biomarkers linked to diseases or treatment responses, facilitating targeted therapies and improved outcomes. Advancements in genomic research and personalized medicine initiatives have expanded their utility across various medical specialties. Regulatory agencies like the FDA actively promote companion diagnostics to support targeted therapy approvals, encouraging healthcare providers to integrate them into clinical decision-making.
In agriculture, DNA sequencing enhances breeding programs for disease-resistant crops and livestock, accelerating genetic trait identification through marker-assisted and genomic selection methods. It also enables precision agriculture by optimizing fertilization, pest control, and irrigation practices based on soil microbiome and nutrient uptake insights. In livestock, DNA sequencing enhances breeding by identifying genetic markers for desirable traits like milk production and disease resistance, improving productivity while minimizing environmental impact.
DNA Sequencing Market Report Highlights
In 2023, the consumables segment held significant revenue share owing to high utilization rate, frequent repurchase, and diverse applications.
In 2023, the next-generation sequencing segment held significant revenue share owing to enhanced throughput, cost-effectiveness, and growing applications in clinical diagnostics.
In 2023, the oncology segment held significant revenue share owing to focus on precision medicine, early detection and diagnosis, and monitoring treatment response.
In 2023, the academic research segment held significant revenue share owing to funding allocation, research intensity, and grant requirements.
In 2023, North America region dominated the global market due to robust healthcare infrastructure, government funding, and high prevalence of genetic disorders.
The market is highly competitive owing to the existence of market players with a global presence, including Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc., Inc. among others.
Polaris Market Research has segmented the DNA Sequencing market report based on product and services, technology, application, end use, and region:
DNA Sequencing, Product and Services Outlook (Revenue - USD Billion, 2019 - 2032)
- Instruments
- Consumables
- Services
DNA Sequencing, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Next-Generation Sequencing
- Sanger Sequencing
- Third Generation Sequencing
- Others
DNA Sequencing, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Clinical Investigation
- Oncology
- Consumer Genomics
- Agrigenomics & Forensics
- Metagenomics
- Epidemiology & Drug Development
- Others
DNA Sequencing, End Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Clinical Research
- Academic Research
- Others
DNA Sequencing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global DNA Sequencing Market Insights
- 4.1. DNA Sequencing - Industry Snapshot
- 4.2. DNA Sequencing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing demand for personalized medicine is projected to spur the product demand
- 4.2.1.2. Advancement in Next-Generation Sequencing (NGS) technologies is expected to drive DNA sequencing market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of sequencing technologies
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. DNA Sequencing Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global DNA Sequencing Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 5.3. Clinical Investigation
- 5.3.1. Global DNA Sequencing Market, by Clinical Investigation, by Region, 2019-2032 (USD Billion)
- 5.4. Oncology
- 5.4.1. Global DNA Sequencing Market, by Oncology, by Region, 2019-2032 (USD Billion)
- 5.5. Consumer Genomics
- 5.5.1. Global DNA Sequencing Market, by Consumer Genomics, by Region, 2019-2032 (USD Billion)
- 5.6. Agrigenomics & Forensics
- 5.6.1. Global DNA Sequencing Market, by Agrigenomics & Forensics, by Region, 2019-2032 (USD Billion)
- 5.7. Metagenomics
- 5.7.1. Global DNA Sequencing Market, by Metagenomics, by Region, 2019-2032 (USD Billion)
- 5.8. Epidemiology & Drug Development
- 5.8.1. Global DNA Sequencing Market, by Epidemiology & Drug Development, by Region, 2019-2032 (USD Billion)
- 5.9. Others
- 5.9.1. Global DNA Sequencing Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global DNA Sequencing Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Next-Generation Sequencing
- 6.3.1. Global DNA Sequencing Market, by Next-Generation Sequencing, by Region, 2019-2032 (USD Billion)
- 6.4. Sanger Sequencing
- 6.4.1. Global DNA Sequencing Market, by Sanger Sequencing, by Region, 2019-2032 (USD Billion)
- 6.5. Third Generation Sequencing
- 6.5.1. Global DNA Sequencing Market, by Third Generation Sequencing, by Region, 2019-2032 (USD Billion)
- 6.6. Others
- 6.6.1. Global DNA Sequencing Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global DNA Sequencing Market, by End-use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 7.3. Hospitals & Clinics
- 7.3.1. Global DNA Sequencing Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Billion)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Global DNA Sequencing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Billion)
- 7.5. Clinical Research
- 7.5.1. Global DNA Sequencing Market, by Clinical Research, by Region, 2019-2032 (USD Billion)
- 7.6. Academic Research
- 7.6.1. Global DNA Sequencing Market, by Academic Research, by Region, 2019-2032 (USD Billion)
- 7.7. Others
- 7.7.1. Global DNA Sequencing Market, by Others, by Region, 2019-2032 (USD Billion)
8. Global DNA Sequencing Market, by Product and Services
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 8.3. Instruments
- 8.3.1. Global DNA Sequencing Market, by Instruments, by Region, 2019-2032 (USD Billion)
- 8.4. Consumables
- 8.4.1. Global DNA Sequencing Market, by Consumables, by Region, 2019-2032 (USD Billion)
- 8.5. Services
- 8.5.1. Global DNA Sequencing Market, by Services, by Region, 2019-2032 (USD Billion)
9. Global DNA Sequencing Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. DNA Sequencing Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. DNA Sequencing Market - North America
- 9.3.1. North America: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.3.2. North America: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.3.3. North America: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.3.4. North America: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.3.5. DNA Sequencing Market - U.S.
- 9.3.5.1. U.S.: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.3.6. DNA Sequencing Market - Canada
- 9.3.6.1. Canada: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4. DNA Sequencing Market - Europe
- 9.4.1. Europe: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.2. Europe: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.3. Europe: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.4. Europe: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.5. DNA Sequencing Market - UK
- 9.4.5.1. UK: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.5.2. UK: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.5.3. UK: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.5.4. UK: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.6. DNA Sequencing Market - France
- 9.4.6.1. France: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.6.2. France: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.6.3. France: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.6.4. France: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.7. DNA Sequencing Market - Germany
- 9.4.7.1. Germany: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.8. DNA Sequencing Market - Italy
- 9.4.8.1. Italy: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.9. DNA Sequencing Market - Spain
- 9.4.9.1. Spain: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.10. DNA Sequencing Market - Netherlands
- 9.4.10.1. Netherlands: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.4.11. DNA Sequencing Market - Russia
- 9.4.11.1. Russia: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5. DNA Sequencing Market - Asia Pacific
- 9.5.1. Asia Pacific: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5.5. DNA Sequencing Market - China
- 9.5.5.1. China: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.5.2. China.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.5.3. China: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.5.4. China: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5.6. DNA Sequencing Market - India
- 9.5.6.1. India: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.6.2. India.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.6.3. India: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.6.4. India: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5.7. DNA Sequencing Market - Japan
- 9.5.7.1. Japan: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5.8. DNA Sequencing Market - Malaysia
- 9.5.8.1. Malaysia: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5.9. DNA Sequencing Market - Indonesia
- 9.5.9.1. Indonesia: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.5.10. DNA Sequencing Market - South Korea
- 9.5.10.1. South Korea: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.6. DNA Sequencing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.6.5. DNA Sequencing Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.6.6. DNA Sequencing Market - South Africa
- 9.6.6.1. South Africa: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.6.7. DNA Sequencing Market - Israel
- 9.6.7.1. Israel: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.6.8. DNA Sequencing Market - UAE
- 9.6.8.1. UAE: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.7. DNA Sequencing Market - Latin America
- 9.7.1. Latin America: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.7.2. Latin America: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.7.3. Latin America: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.7.4. Latin America: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.7.5. DNA Sequencing Market - Mexico
- 9.7.5.1. Mexico: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.7.6. DNA Sequencing Market - Brazil
- 9.7.6.1. Brazil: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
- 9.7.7. DNA Sequencing Market - Argentina
- 9.7.7.1. Argentina: DNA Sequencing Market, by Application, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: DNA Sequencing Market, by Product and Services, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: DNA Sequencing Market, by Technology, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: DNA Sequencing Market, by End-use, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abcam plc
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Agilent Technologies, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Becton, Dickinson and Company (BD)
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Bio-Rad Laboratories, Inc.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Bio-Techne Corporation
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Cell Biolabs, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Cell Signaling Technology, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Danaher Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. GenScript Biotech Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Merck KGaA
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. PerkinElmer, Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Promega Corporation
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Qiagen N.V.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. SignalChem Pharmaceuticals Inc.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Thermo Fisher Scientific Inc.
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
